ACE2 and viral infectious disease: The fact that SARS-CoV-2 requires the presence of the ACE2 protein to enter in the cell membrane [3] and the association between a higher rate of complications in hypertensive patients, have suggested that angiotensin converting enzyme inhibitors or angiotensin II receptor blockers could facilitate the first phase of viral infection.